Dexamethasone Posterior Segment Drug Delivery System Versus Laser Photocoagulation in Patients With Diabetic Macular Edema
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 17 Apr 2019
Price : $35 *
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Sponsors Allergan
- 15 Apr 2019 Planned End Date changed from 31 Dec 2019 to 11 Oct 2019.
- 15 Apr 2019 Planned primary completion date changed from 31 Dec 2019 to 11 Oct 2019.
- 15 Apr 2019 Status changed from recruiting to active, no longer recruiting.